Effects of lead in the laboratory mouse. 1. Influence of pregnancy upon absorption, retention, and tissue distribution of radiolabeled lead.
Whole-body retention and excretion following a single oral dose of radiolabeled lead (203Pb) in chronically lead-exposed pregnant BK:W mice were examined over 10-13 days. This was compared with values in similarly treated nonpregnant females and in ip injected females. Whole-body and bone retention were greater in injected than in orally dosed nonpregnant females; gastrointestinal absorption was estimated from this difference. Whole-body retention in the pups was measured at birth and at the end of the experiment. Whole-body retentions in pregnant females and in their pups at birth were significantly raised after treatment at Gestational Day 17, but not after treatment at Gestational Day 11, 14, 20, 23, or 26. Pup body burdens at birth were significantly and positively correlated with maternal retention. Measurement of radioactivity in bone, kidney, brain, heart, and liver of adults at the end of the experiments showed significantly increased levels in bone and kidney from females treated at Gestational Day 17 and in bone from females treated at Gestational Day 11. Lead excretion did not differ significantly among the groups but the total lead content of the femur was significantly raised in females treated at Gestational Days 17 and 26. Thus, these experiments provide evidence that lead absorption and retention in mice are markedly increased in the latter stages of pregnancy.
D000818:Animals; D000831:Animals, Newborn / Q000378:metabolism; D001822:Body Burden; D005260:Female; D005333:Fetus / Q000378:metabolism; D007408:Intestinal Absorption; D007854:Lead / Q000378:metabolism*; D051379:Mice; D011247:Pregnancy; D011270:Pregnancy, Animal / Q000378:metabolism*; D014018:Tissue Distribution
D007854:Lead